Albert A. Manzone was appointed as Interim President and Chief Executive Officer at PERRIGO Co plc.
“As previously announced, on June 7, 2026, the Board appointed Albert A. Manzone as the Company’s Interim President and Chief Executive Officer.”
PERRIGO Co plc — fact timeline
Source-grounded facts extracted from PERRIGO Co plc's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Omer Gajial was appointed as Director at PERRIGO Co plc.
“On June 30, 2026, the Board of Directors (the “Board”) of Perrigo Company plc (the “Company”) appointed Salman Amin and Omer Gajial to serve as members of the Board effective as of June 30, 2026.”
Salman Amin was appointed as Director at PERRIGO Co plc.
“On June 30, 2026, the Board of Directors (the “Board”) of Perrigo Company plc (the “Company”) appointed Salman Amin and Omer Gajial to serve as members of the Board effective as of June 30, 2026.”
Albert A. Manzone was appointed as Interim President and Chief Executive Officer at PERRIGO Co plc.
“On June 7, 2026, the Board appointed Albert A. Manzone, Director and member of the Audit Committee of the Board, as the Company’s Interim President and Chief Executive Officer.”
Patrick Lockwood-Taylor resigned as member of the Board of Directors at PERRIGO Co plc.
“On June 7, 2026, Patrick Lockwood-Taylor resigned, effective immediately, as President and Chief Executive Officer and as a member of the Board of Directors”
Patrick Lockwood-Taylor resigned as President and Chief Executive Officer at PERRIGO Co plc.
“On June 7, 2026, Patrick Lockwood-Taylor resigned, effective immediately, as President and Chief Executive Officer and as a member of the Board of Directors (the "Board") of Perrigo Company plc (the "Company").”
PERRIGO Co plc reported the first quarter ended March 28, 2026 results: revenue $969 million, EPS $(2.81). Guidance reaffirmed.
“of Women’s Health products. Core organic net sales comprised net pricing of 0.2% and volume/mix of -11.0%. • All In reported net sales declined 7.2% year over year to $969 million. The decrease was driven by the same factors impacting Core net sales, partially offset by Infant Formula net sales growth. Gross Margin • Reported gross margin was 33.6%, a”
PERRIGO Co plc shareholders approved Renew the Board’s authority to opt-out of statutory pre-emption rights under Irish law at the 2026-04-30 meeting.
“6. Renew the Board’s authority to opt-out of statutory pre-emption rights under Irish law: For Against Abstain Broker Non-Votes 111,150,726 4,943,238 120,337 —”
PERRIGO Co plc shareholders approved Renew the Board’s authority to issue shares under Irish law at the 2026-04-30 meeting.
“5. Renew the Board’s authority to issue shares under Irish law: For Against Abstain Broker Non-Votes 115,179,070 949,911 85,320 —”
PERRIGO Co plc shareholders approved Approve the 2026 Plan at the 2026-04-30 meeting.
“4. Approve the 2026 Plan: For Against Abstain Broker Non-Votes 101,486,928 5,721,273 79,512 8,926,588”
PERRIGO Co plc shareholders approved Advisory vote on executive compensation at the 2026-04-30 meeting.
“3. Advisory vote on executive compensation: For Against Abstain Broker Non-Votes 105,407,787 1,748,436 131,490 8,926,588”
PERRIGO Co plc shareholders approved Ratify, in a non-binding advisory vote, the appointment of Ernst & Young LLP as the Company’s independent auditor for the year ending December 31, 2026, and authorize, the Board of Directors, acting through the Audit Committee, to fix the remuneration of the auditor at the 2026-04-30 meeting.
“2. Ratify, in a non-binding advisory vote, the appointment of Ernst & Young LLP as the Company’s independent auditor for the year ending December 31, 2026, and authorize, the Board of Directors, acting through the Audit Committee, to fix the remuneration of the auditor: For Against Abstain Broker Non-Votes 113,450,862 2,682,439 81,000 —”
PERRIGO Co plc shareholders approved Election of directors to hold office until the 2027 Annual General Meeting of Shareholders at the 2026-04-30 meeting.
“1. Election of directors to hold office until the 2027 Annual General Meeting of Shareholders: Nominee For Against Abstain Broker Non-Votes Bradley A. Alford 105,969,898 1,290,063 27,752 8,926,588 Orlando D. Ashford 95,646,295 11,591,846 49,572 8,926,588 Julia M. Brown 101,052,669 5,751,749 483,295 8,926,588 Kevin Egan 106,601,125 647,205 39,383 8,926,588 Patrick Lockwood-Taylor 106,442,547 808,941 36,225 8,926,588 Albert A. Manzone 92,116,246 15,132,058 39,409 8,926,588 Donal O’Connor 106,175,693 1,049,777 62,243 8,926,588 Geoffrey M. Parker 106,350,338 897,163 40,212 8,926,588 Jonas Samuelson 103,832,794 3,410,983 43,936 8,926,588”
PERRIGO Co plc completed a disposition involving Karo Healthcare AB for €305.6 million in upfront cash plus up to €27.0 million contingent consideration (closed 2026-04-30).
“On April 30, 2026, the Transaction closed pursuant to the terms of the Agreement. In connection with the closing of the Transaction, Karo made a cash payment to the Company of €305.6 million, including €5.6 million in net working capital adjustments. In addition, the Company may be entitled to additional contingent cash consideration of up to €27.0 million upon”
PERRIGO Co plc entered into Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A. and J. P. Morgan SE, as administrative agent, JPMorgan Chase Bank, N.A., as collateral agent and the other lenders party thereto valued at $1.0 billion revolving credit facility (effective 2026-03-20).
“On March 20, 2026 (the “Effective Date”), the Company entered into an Amended and Restated Credit Agreement (the “Amended and Restated Credit Agreement”) with Perrigo Investments, the other subsidiaries of the Company named therein, JPMorgan Chase Bank, N.A. and J. P. Morgan SE, as administrative agent, JPMorgan Chase Bank, N.A., as collateral agent and the other lenders party thereto.”
PERRIGO Co plc amended credit facility with JPMorgan Chase Bank, N.A. and J. P. Morgan SE, as administrative agent maturing March 20, 2031.
“On March 20, 2026 (the “Effective Date”), the Company entered into an Amended and Restated Credit Agreement (the “Amended and Restated Credit Agreement”)”
Ronald Janish retired as Executive Vice President, Global Operations and Supply Chain at PERRIGO Co plc.
“Ronald Janish and Perrigo Company plc (“Perrigo” or the “Company”) reached mutual agreement regarding his planned retirement.”
Katherine Doyle departed as Director at PERRIGO Co plc.
“On January 29, 2025, Katherine Doyle, an independent member of the Perrigo Company plc (the “Company”) Board of Directors, advised Perrigo’s Nominating & Governance Committee that she will not stand for re-election to our Board of Directors at the Company’s annual general meeting of shareholders in 2025 and intends to retire from our Board at that time.”
Jonas Samuelson was appointed as Director at PERRIGO Co plc.
“On January 15, 2025, the Board of Directors of Perrigo Company plc (the “Company” or “Perrigo”) appointed Jonas Samuelson to serve as a member of the Company’s board of directors (the “Board”) effective as of January 15, 2025.”
Todd Penegor resigned as director at PERRIGO Co plc.
“On July 24, 2024, Todd Penegor advised Perrigo Company plc (“Perrigo” or the “Company”) that he would be resigning from the Company’s board of directors (the “Board”), effective July 31, 2024.”
Todd Penegor was appointed as Director at PERRIGO Co plc.
“appointed Todd Penegor to serve as a member of the Company’s board of directors (the “Board”), to be effective June 21, 2024.”
Kyle L. Hanson departed as Executive Vice President, General Counsel and Corporate Secretary at PERRIGO Co plc.
“Effective May 30, 2024, Ms. Hanson will step down from her positions as Executive Vice President (“EVP”), General Counsel and Corporate Secretary of the Company and relevant affiliates.”
PERRIGO Co plc reported first quarter ended March 30, 2024 results: revenue $1.1 billion, EPS $0.03. Guidance reaffirmed.
“Business Recently Announced Plan to Divest HRA Rare Diseases Business; Expects to Redeploy Proceeds for Debt Paydown First Quarter 2024 Highlights: • First quarter net sales of $1.1 billion declined 8.4% versus the prior year quarter. First quarter organic 1 net sales decreased 7.0%, due primarily to 1) -4.3 percentage points impact due to lower net sales in infant”
Svend Andersen retired as Executive Vice President and President, Consumer Self-Care International at PERRIGO Co plc.
“Svend Andersen and Perrigo Company plc (“Perrigo” or the “Company”) reached mutual agreement regarding his retirement, such that Mr. Andersen will no longer serve as Executive Vice President and President, Consumer Self-Care International of the Company and all relevant subsidiaries and affiliates, to be effective July 31, 2024”
Erica L. Mann departed as Director at PERRIGO Co plc.
“On March 2, 2024, Erica L. Mann, an independent member of the Perrigo Company plc (the “Company”) Board of Directors, advised Perrigo’s Nominating & Governance Committee that she will not stand for re-election to our Board of Directors at the Company’s annual general meeting of shareholders in 2024 and intends to retire from our Board at that time.”
PERRIGO Co plc reported financial results for the fourth quarter ended December 31, 2023.
“On February 27, 2024, Perrigo Company plc (the “Company”) released earnings for the fourth quarter ended December 31, 2023.”
PERRIGO Co plc amended Amendment No. 1 and Incremental Assumption Agreement with JPMorgan Chase Bank, N.A., as administrative agent valued at $300.0 million (effective 2023-12-15).
“On December 15, 2023, Perrigo Investments, LLC (the “ Borrower ”), Perrigo Company plc (the “ Company ”), the guarantors party thereto, each lender party thereto and JPMorgan Chase Bank, N.A., as administrative agent (in such capacity, the “ Administrative Agent ”), entered into Amendment No. 1 and Incremental Assumption Agreement”
PERRIGO Co plc reported the third quarter ended September 30, 2023 results: revenue $1.1 billion, EPS $0.11.
“Third quarter net sales of $1.1 billion grew 2.2% versus the prior year quarter.”
James Dillard III departed as Executive Vice President & President, Consumer Self-Care Americas at PERRIGO Co plc.
“On September 11, 2023, James Dillard III and Perrigo Company plc (“Perrigo” or the “Company”) agreed to a mutual separation, such that Mr. Dillard will no longer serve as Executive Vice President (“EVP”) & President, Consumer Self-Care Americas of the Company and all relevant subsidiaries and affiliates effective the same day.”
Julia Brown was appointed as director at PERRIGO Co plc.
“On August 3, 2023, the Board of Directors of Perrigo Company plc (the “Company” or “Perrigo”) appointed Julia Brown to serve as a member of the Company’s board of directors (the “Board”), to be effective November 1, 2023.”
Murray Kessler retired as President and Chief Executive Officer at PERRIGO Co plc.
“following the retirement of Murray Kessler from those same positions on the same day”
Patrick Lockwood-Taylor was appointed as President and Chief Executive Officer at PERRIGO Co plc.
“announced the appointment of Mr. Patrick Lockwood-Taylor, 54, as President, CEO and director, effective June 30, 2023”
PERRIGO Co plc shareholders approved Approve the creation of distributable reserves by reducing some or all of the Company's share premium at the 2023-05-04 meeting.
“7. Approve the creation of distributable reserves by reducing some or all of the Company's share premium: Votes For Votes Against Abstentions Broker Non-Votes 122,771,535 302,287 227,912 —”
PERRIGO Co plc shareholders approved Renew the Board's authority to opt-out of statutory pre-emption rights under Irish law at the 2023-05-04 meeting.
“6. Renew the Board's authority to opt-out of statutory pre-emption rights under Irish law: Votes For Votes Against Abstentions Broker Non-Votes 121,035,864 2,210,786 55,084 —”
PERRIGO Co plc shareholders approved Renew the Board's authority to issue shares under Irish law at the 2023-05-04 meeting.
“5. Renew the Board's authority to issue shares under Irish law: Votes For Votes Against Abstentions Broker Non-Votes 120,249,204 2,891,528 161,002 —”
PERRIGO Co plc shareholders approved Advisory vote on the frequency of future advisory votes on executive compensation at the 2023-05-04 meeting.
“4. Advisory vote on the frequency of future advisory votes on executive compensation: 1 year 2 year 3 year Abstentions Broker Non-Votes 107,429,468 127,451 8,267,824 207,075 7,269,915”
PERRIGO Co plc shareholders approved Advisory vote on executive compensation at the 2023-05-04 meeting.
“3. Advisory vote on executive compensation: Votes For Votes Against Abstentions Broker Non-Votes 77,848,010 38,080,510 103,298 7,269,915”
PERRIGO Co plc shareholders approved Ratify, in a non-binding advisory vote, the appointment of Ernst & Young LLP as the Company's independent auditor for the year ending December 31, 2023, and authorize, in a binding vote, the Board of Directors, acting through the Audit Committee, to fix the remuneration of the auditor at the 2023-05-04 meeting.
“2. Ratify, in a non-binding advisory vote, the appointment of Ernst & Young LLP as the Company's independent auditor for the year ending December 31, 2023, and authorize, in a binding vote, the Board of Directors, acting through the Audit Committee, to fix the remuneration of the auditor: Votes For Votes Against Abstentions Broker Non-Votes 122,552,222 697,972 51,540 —”
PERRIGO Co plc shareholders approved Election of directors to hold office until the 2024 Annual General Meeting of Shareholders at the 2023-05-04 meeting.
“1. Election of directors to hold office until the 2024 Annual General Meeting of Shareholders: Nominee Votes For Votes Against Abstentions Broker Non-Votes Bradley A. Alford 111,592,058 4,373,193 66,567 7,269,915 Orlando D. Ashford 109,492,962 6,476,921 61,935 7,269,915 Katherine C. Doyle 114,732,070 1,190,202 109,546 7,269,915 Adriana Karaboutis 106,885,766 9,083,652 62,400 7,269,915 Murray S. Kessler 114,747,882 1,240,742 43,194 7,269,915 Jeffrey B. Kindler 111,077,497 4,872,272 82,049 7,269,915 Erica L. Mann 99,627,449 16,336,273 68,096 7,269,915 Albert A. Manzone 112,661,583 3,234,202 136,033 7,269,915 Donal O'Connor 114,159,014 1,801,001 71,803 7,269,915 Geoffrey M. Parker 109,562,945 6,406,620 62,253 7,269,915”
PERRIGO Co plc reported first quarter ended April 1, 2023 results: revenue $1.2 billion, EPS a loss of $(0.01). Guidance reaffirmed.
“Perrigo Reports First Quarter Fiscal Year 2023 Financial Results From Continuing Operations First Quarter 2023 Highlights: • First quarter net sales grew 10.0% versus the prior year quarter to $1.2 billion. Constant currency net sales (1) increased 13.0% and organic (2) net sales grew 6.4% compared to the prior year quarter. • Consumer Self-Care Americas ("CSCA") and Consumer Self-Care International ("CSCI") segments delivered strong net sales growth of 7.6% and 14.7%, respectively, compared to the prior year quarter. CSCI achieved record net sales in the quarter, highlighted by constant currency net sales growth of 23.6% compared to the prior year quarter. • First quarter GAAP ("reported") gross margin was 35.0%, a 360 basis points improvement compared to the prior year quarter. Non-GAAP ("adjusted") gross margin was 37.5%, a 400 basis points improvement compared to the prior year quarter. • First quarter reported earnings per share ("EPS") was a loss of $(0.01), compared to a loss of”
Murray S. Kessler departed as President and Chief Executive Officer at PERRIGO Co plc.
“On May 4, 2023, Murray S. Kessler, President and Chief Executive Officer of Perrigo Company plc (“Perrigo” or the “Company”) advised Perrigo’s Nominating & Governance Committee of his intent to retire as President and Chief Executive Officer, with a target effective date of July 31, 2023.”
PERRIGO Co plc reported fiscal year ended December 31, 2022 results: revenue $4.5 billion, EPS ($0.97).
“Reports Fourth Quarter & Fiscal Year 2022 Financial Results From Continuing Operations Highlights: • Perrigo fiscal year net sales grew 7.6% versus the prior year to $4.5 billion. Constant currency net sales (1) increased 12.8% and organic (2) net sales grew a robust 8.8% compared to the prior year. • Fourth quarter net sales grew 4.6% to $1.2 billion”
PERRIGO Co plc reported the Fourth quarter ended December 31, 2022 results: revenue $1.2 billion, EPS ($0.09).
“• Fourth quarter net sales grew 4.6% to $1.2 billion versus the prior year quarter, or 9.6% on a constant currency basis.”
Theodore R. Samuels departed as Director at PERRIGO Co plc.
“On February 7, 2023, Theodore R. Samuels, an independent member of the Perrigo Company plc Board of Directors, advised Perrigo’s Nominating & Governance Committee that he will not stand for re-election to our Board of Directors at the Company’s annual general meeting of shareholders in 2023 and intends to retire from our Board at that time.”
PERRIGO Co plc reported fiscal 2022 results: EPS Company updates fiscal 2022 adjusted EPS range outlook to $2.00-$2.10 from $2.25-$2.35. Guidance lowered.
“Company updates fiscal 2022 adjusted EPS range outlook to $2.00-$2.10 from $2.25-$2.35, as lower sales volumes in CSCA and $0.10 from the worsening impact of currency translation are expected to more than offset solid year-to-date performance in the 1 international business and accretion from the purchase of the Gateway plant in the U.S.”
PERRIGO Co plc reported third quarter ended October 1, 2022 results: EPS Third quarter reported net earnings (loss) per diluted share ("EPS") was a loss of ($0.39), as compared to a loss of ($0.
“Perrigo achieved third quarter net sales of $1.1 billion, an increase of 5.5%, or 12.3% excluding the impact of currency translation, versus the prior year quarter.”
Albert A. Manzone was appointed as Director at PERRIGO Co plc.
“On July 11, 2022, the Board of Directors of Perrigo Company plc (the “Company” or “Perrigo”) appointed Albert A. Manzone to serve as a member of the Company’s board of directors (the “Board”), to be effective July 30, 2022.”
Eduardo Bezerra was appointed as EVP and CFO at PERRIGO Co plc.
“The Company has appointed Mr. Eduardo Bezerra, 47, as EVP and CFO, effective May 16, 2022, succeeding Mr. Silcock, who will serve in an advisory capacity until his retirement on July 15, 2022.”
Ray Silcock retired as Chief Financial Officer (CFO) and principal accounting officer at PERRIGO Co plc.
“Additionally, as previously announced, Mr. Ray Silcock informed the Company of his intent to retire as Chief Financial Officer (CFO) and principal accounting officer of the Company, to be effective July 15, 2022.”
Kyle Hanson was appointed as EVP, General Counsel and Corporate Secretary at PERRIGO Co plc.
“The Company has appointed Ms. Kyle Hanson, 57, to assume the roles of EVP, General Counsel and Corporate Secretary, effective June 1, 2022.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.